Drug Shortage Report for DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP
| Report ID | 228098 |
| Drug Identification Number | 00761826 |
| Brand name | DOPAMINE HCL 1.6MG/ML DEXTROSE 5% INJ USP |
| Common or Proper name | Dopamine/Dextrose |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE DOPAMINE HYDROCHLORIDE |
| Strength(s) | 50MG 1.6MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 400 mg (JB0842) |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | 2024-05-13 |
| Actual start date | 2024-05-13 |
| Estimated end date | 2024-06-28 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2024-05-16 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2024-05-16 | French | Compare |
| v1 | 2024-05-16 | English | Compare |
Showing 1 to 2 of 2